GK Strategy Rebrand

GK Strategy, the strategic communications and public affairs consultancy, and our sister political due diligence adviser, GK Intelligence, have merged. To mark bringing the businesses together, and to celebrate 10 years as a consultancy, we have undertaken a full rebrand of the business. The rebrand sees GK shift to a lower case ‘gk’ and adopt a new colour palette, better representing its make-up as a dynamic, youthful disrupter. Founded 10 years ago by Robin Grainger and Luke...

Harry Shackleton 26th Nov, 2018 Insight 2 min read

GK Strategy shortlisted for Consultancy of the Year

We are very proud to announce we have been shortlisted for consultancy of the year at the PRCA Public Affairs Awards, an award we previously won in 2015. The PRCA Public Affairs Awards celebrate the very best of the UK public affairs industry. The awards ceremony will be held on Thursday 29th November. When receiving the news our CEO Robin Grainger said… “Among a very strong field, it is fantastic to be shortlisted for Consultancy of the Year at the PRCA Public...

Harry Shackleton 26th Oct, 2018 Insight 3 min read

Award nomination for GK

We are delighted to announce that GK Strategy have been shortlisted for Best Specialist Due Diligence Provider at Unquote’s British Private Equity Awards 2018. The British Private Equity Awards celebrate innovation and excellence in private equity and venture capital, as well as honoring the industry’s ability to help build British businesses – and in doing so, foster the wider economy. Over the past year, we have implemented innovative new services, expanded our international...

Harry Shackleton 7th Sep, 2018 Impact 3 min read

What can social prescribing mean for private equity?

The government has said that they will invest nearly £4.5 million in ‘social prescribing.’ This will include programmes that refer patients to local voluntary and community services such as walking clubs, gardening or arts activities. A recent UK study found that after 3 to 4 months, 80% of patients referred to a social prescribing scheme had reduced their use of A&E, outpatient appointments and inpatient admissions. What is ‘social...

Harry Shackleton 16th Aug, 2018 Insight 3 min read

Cash flow is king. Why consumers, not government, will decide the future of Oxfam.

The Oxfam scandal shows no sign of slowing down following the Chief Executive’s frankly disastrous interview (discussing “murdering babies” is never a good idea). Attention has thus far focused largely on the likelihood of UK and EU public money being withdrawn. Any drop in funding is obviously significant, particularly when the public money in question makes up 43% of funding (£176m), according to the

Missed the Labour reshuffle? Here are the 3 things you need to know

Following last week’s slightly damp squib of a Government reshuffle, the announcement at 7pm on a Friday night that Jeremy Corbyn was also reshuffling his team was hardly surprising. While nothing’s changed within the Shadow Cabinet, some interesting appointments have been made in the junior shadow ministerial ranks. Here’s what you need to know: Labour’s rapprochement Following the rather public bloodletting of mass shadow cabinet resignations...

Harry Shackleton 17th Jan, 2018 Insight 3 min read

GK’s response to the reshuffle – what has actually changed?

There has been a lot of noise around politics this week, but as the coverage of the reshuffle fades we are left wondering: what has actually changed? So, here is what is different at the end of the week than the beginning: We have a weaker Prime Minister. One of the key objectives of the reshuffle was for Theresa May to reassert her authority, with a reshuffle that was heavily trailed in the press as making significant changes to the Cabinet. The reality was...

Harry Shackleton 12th Jan, 2018 Insight 3 min read

The Life Sciences Sector Deal: Transformative Healthcare Innovation?

As part of the Government’s Industrial Strategy, the Secretary of State for Business, Energy and Industrial Strategy, Greg Clark has announced a Sector Deal between government and the life sciences industry. The Life Sciences Sector Deal, the first of four outlined in the

Harry Shackleton 22nd Dec, 2017 Insight